Causes of impaired delivery of hemodialysis prescription

Artificial Organs

Volumn 30, Issue 11, 2006, Pages 878-881

  Fourtounas, Costas ^a,b   Kopelias, Ioannis ^a   Paraskevopoulos, Aristides ^a   Dimitriadis, George ^a   Agroyannis, Basil ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

Adequacy; Hemodialysis; Urea kinetics; Vascular access

Indexed keywords

BLOOD; DIALYSIS; HEMODIALYZERS; KINETIC THEORY; METABOLISM; UREA;

ABNORMAL VALUES; ADEQUACY; AVERAGE VALUES; BLOOD FLOW; HAEMODIALYSIS; PROSPECTIVE STUDY; UREA KINETIC; UREA KINETIC MODELING; VALUE GROUP; VASCULAR ACCESS;

KINETICS;

UREA;

ADULT; AGED; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; DEMOGRAPHY; EUROPE; FEMALE; HEMODIALYSIS; HUMAN; KINETICS; MALE; MEDICAL RECORD; PRESCRIPTION; PRIORITY JOURNAL; VASCULAR ACCESS;

FISTULA;

EID: 33750363449     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2006.00315.x     Document Type: Article

References (18)

1. Gotch FA, Srgent JA. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985;28:526-34.
2. Gotch FA, Levin NW, Port FK. Clinical outcome relative to the dose of dialysis is not what you think: the fallacy of the mean. Am J Kidney Dis 1997;30:1-15.
3. Port FK, Ashby VB, Dhingra RK. Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 2002;13:1061-6.
4. Held PJ, Port FK, Wolfe RA. The dose of hemodialysis and patient mortality. Kidney Int 1996;50:550-6.
5. National Kidney Foundation. K/DOQI clinical practice guidelines for hemodialysis adequacy: update 2000. Am J Kidney Dis 2001;37:S7-S64.
6. Eknoyan G, Beck GJ, Cheung AK, The Hemodialysis (HEMO) Study Group. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002;347:2010-9.
7. Port FK, Pisoni RL, Bragg-Gresham JL. DOPPS estimates of patient life years attributable to modifiable hemodialysis treatment practices in the United States. Blood Purif 2004;22:175-80.
8. Port FK, Wolfe RA, Hulbert-Shearon TE. High dialysis dose is associated with lower mortality among women but not among men. Am J Kidney Dis 2004;43:1014-23.
9. Parker TF, Husni L, Huang W. Survival of hemodialysis patients in the United States is improved with a great quantity of dialysis. Am J Kidney Dis 1994;23:670-80.
10. Rocco MV, Burkart JM. Prevalence of missed treatments and early sign-offs in hemodialysis patients. J Am Soc Nephrol 1993;4:1178-83.
11. Pederson WC, Dunlay R, Llach F. Two-needle calculation of recirculation compared with the standard three-needle method. Clin Nephrol 1990;33:203-6.
12. Delmez JA, Weerts CA, Hasamear PD, Windus DW. Severe dialyzer dysfunction undetectable by standard reprocessing validation tests. Kidney Int 1989;36:478-84.
13. Coyne DW, Delmez J, Spence G, Windus DW. Impaired delivery of hemodialysis prescriptions: an analysis of causes and an approach to evaluation. J Am Soc Nephrol 1997;8:1315-8.
14. Daugirdas JT. Rapid methods of estimating Kt/V: three formulas compared. ASAIO Trans 1990;36:362-4.
15. Parker TF. Trends and concepts in the preparation and delivery of dialysis in the United States. Semin Nephrol 1992;12:267-75.
16. Sargent JA. Shortfalls in the delivery of dialysis. Am J Kidney Dis 1990;15:500-10.
17. Seghal AR, Snow RJ, Singer ME, et al. Barriers to adequate delivery of hemodialysis. Am J Kidney Dis 1998;31:593-601.
18. Palevsky PM, Washington MS, Stevenson JA, et al. Barriers to the delivery of adequate hemodialysis in ESRD Network 4. Adv Ren Replace Ther 2000;7(Suppl. 1):S11-20.